RELB Antikörper (AA 395-444)
Kurzübersicht für RELB Antikörper (AA 395-444) (ABIN6744395)
Target
Alle RELB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 395-444
-
Spezifität
- Human RELB
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Rabbit (92%) Mouse, Dog, Horse (85%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa395-444 of human RELB (Q01201, NP_006500). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Opossum (100%), Marmoset, Elephant, Panda, Rabbit (92%), Galago, Mouse, Dog, Bat, Horse (85%).
Type of Immunogen: Synthetic peptide
-
-
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (AA 1-579) antibody
RELB Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (AA 1-579) antibodyRELB Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) antibodyKD Validated RELB Reaktivität: Human WB, FACS, ICC Wirt: Kaninchen Monoclonal 24GB925 unconjugated Recombinant Antibody
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (AA 273-443) antibodyRELB Reaktivität: Human IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 2E4B1 unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (C-Term) antibodyRELB Reaktivität: Human, Maus WB, IP, IHC (p), ChIP Wirt: Kaninchen Polyclonal unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (pSer573) antibodyRELB Reaktivität: Human, Maus WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (AA 248-492) antibodyRELB Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) antibodyKD Validated RELB Reaktivität: Human WB, FACS Wirt: Kaninchen Monoclonal 24GB5070 unconjugated Recombinant Antibody
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) antibodyRELB Reaktivität: Human, Maus WB Wirt: Maus Monoclonal 4C5 unconjugated
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (AA 1-579) antibodyRELB Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))
-
Andere Bezeichnung
- RELB
-
Hintergrund
-
Name/Gene ID: RELB
Synonyms: RELB, REL-B, Transcription factor RelB, I-Rel, IREL -
Gen-ID
- 5971
-
NCBI Accession
- NP_006500
-
UniProt
- Q01201
-
Pathways
- NF-kappaB Signalweg, RTK Signalweg
Target
-
